Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ClickSlim vs PreventiveMD

ClickSlim
Graded #491

Lower grade

vs+26.500000000000007
PreventiveMD
Graded #53

Higher grade

The verdict

PreventiveMD takes it — 76.4/100 to 49.9/100.

PreventiveMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PreventiveMD is a physician-guided telehealth platform for GLP-1 weight loss and peptide therapy, offering compounded semaglutide from $83/mo all-in and compounded tirzepatide from $97/mo all-in, plus brand…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePreventiveMD +53
32
85
Dose & formulationPreventiveMD +30
52
82
Clinical oversightPreventiveMD +22
60
82
Labs & monitoringPreventiveMD +1
52
53
FulfillmentPreventiveMD +18
65
83
Contract termsPreventiveMD +6
49
55
ClickSlim · left barPreventiveMD · right bar

The numbers

MetricClickSlimPreventiveMD
WeighScore49.9/10076.4/100
GradeCC
Scorecard rank#491#53
SemaglutideNot disclosed$83/mo (as low as, term not published, all-in, compounded)
Tirzepatide$349/mo (compounded)$97/mo (as low as, term not published, all-in, compounded)
CoverageCoverage not published36 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
ClickSlim

Graded #491 · C

Strengths

  • Both the introductory and the ongoing price are published, so the step-up is visible before you buy
  • States plainly that it is not a pharmacy or a drug manufacturer and that medication is dispensed by a licensed third party
  • Text support line published with stated hours
  • LegitScript certification verified against the issued seal, not just the badge

Where it loses points

  • Its own NAD+ product card is labelled CONTAINS TIRZEPATIDE, which contradicts the product it is selling
  • No state list is published; the site says only that services are available in most States
  • Prices are among the highest in the category, at $349 ongoing for tirzepatide
  • Registered at a Sheridan, Wyoming suite address commonly used as a mail-forwarding and registered-agent address
  • Terms set arbitration in San Diego under California law while the company address is in Wyoming
PreventiveMD

Graded #53 · C

Strengths

  • Compounded semaglutide from $83/mo and tirzepatide from $97/mo, billed as one all-in monthly price
  • Brand Wegovy, Zepbound, and Foundayo (oral GLP-1) available on the same platform
  • US-licensed provider reviews requests within 24 hours — no video visit required
  • You aren't charged until a provider approves; checkout places an authorization hold only
  • LegitScript-certified; works exclusively with state-licensed US 503A compounding pharmacies

Where it loses points

  • Both figures are 'as low as' rates and the qualifying term is not published anywhere — the checkout is gated, so whether $97 is month-to-month or a multi-month prepay cannot be established before signing up
  • Brand-name routes are priced separately and do carry a fee: $49/mo membership plus medication from $149/mo for Foundayo and Wegovy, from $299/mo for Zepbound
  • No state count is published, and a state-variant waitlist implies some states are unserved
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard